ConductScience.org, home

Paper22200728

The endothelin receptor antagonist bosentan improves peripheral endothelial function in patients with type 2 diabetes mellitus and microalbuminuria: a randomised trial.

Rafnsson A and 5 others. Diabetologia, 2012. Cited by 63 papers, by iCite.

Cite this record

ConductScience Library. The endothelin receptor antagonist bosentan improves peripheral endothelial function in patients with type 2 diabetes mellitus and microalbuminuria: a randomised trial. Papers, record 22200728. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/22200728

Download JSON
Disease
type 2 diabetes mellitus613 drugs
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The endothelin receptor antagonist bosentan improves peripheral endothelial function in patients with type 2 diabetes mellitus and microalbuminuria: a randomised trial.
PubMed
Journal
Diabetologia
PubMed
Year
2012
PubMed
Publication types
Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
63
iCite
Relative citation ratio, by iCite
2.06
iCite
Revised in PubMed
2021-10-21
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Rafnsson AA
2Böhm FF
3Settergren MM
4Gonon AA
5Brismar KK
6Pernow JJ

Source PubMed

Download CSV of authors

Topics21

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AlbuminuriaMajor topic
Antihypertensive AgentsMajor topic
Diabetes Mellitus, Type 2Major topic
Diabetic AngiopathiesMajor topic
Endothelin Receptor AntagonistsMajor topic
Endothelium, VascularMajor topic
SulfonamidesMajor topic
Aged
Bosentan
Brachial Artery
Diabetic Nephropathies
Double-Blind Method
Female
Humans
Hyperemia
Male
Microvessels
Middle Aged
Peripheral Vascular Diseases
Severity of Illness Index
Vasodilation

Source PubMed

Download CSV of topics

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT01357109Effect of Bosentan on Endothelial Function in Patients With Type 2 DiabetesDerived from the trialYes

Source ClinicalTrials.gov

Download CSV of trials

References26

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
110792555Adverse endothelial function and the insulin resistance syndrome.J Intern Med2000https://conductscience.org/library/papers/10792555PubMed
212453909Endothelin contributes to basal vascular tone and endothelial dysfunction in human obesity and type 2 diabetes.Diabetes2002https://conductscience.org/library/papers/12453909PubMed
318212505Endothelin-A receptor blockade increases nutritive skin capillary circulation in patients with type 2 diabetes and microangiopathy.J Vasc Res2008https://conductscience.org/library/papers/18212505PubMed
42198188Elevated plasma endothelin in patients with diabetes mellitus.Diabetologia1990https://conductscience.org/library/papers/2198188PubMed
520167702Avosentan for overt diabetic nephropathy.J Am Soc Nephrol2010https://conductscience.org/library/papers/20167702PubMed
611004428Possible pathophysiological mechanisms for diabetic angiopathy in type 2 diabetes.J Diabetes Complications2000https://conductscience.org/library/papers/11004428PubMed
718441323Cholesterol lowering is more important than pleiotropic effects of statins for endothelial function in patients with dysglycaemia and coronary artery disease.Eur Heart J2008https://conductscience.org/library/papers/18441323PubMed
820733096Long-term administration of endothelin receptor antagonist improves coronary endothelial function in patients with early atherosclerosis.Circulation2010https://conductscience.org/library/papers/20733096PubMed
917645585Endothelial dysfunction in insulin resistance and type 2 diabetes.J Intern Med2007https://conductscience.org/library/papers/17645585PubMed
101955098Prevalence of micro- and macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in European type 2 (non-insulin-dependent) diabetic patients.Diabetologia1991https://conductscience.org/library/papers/1955098PubMed
117545695
Altered relation between circulating levels of insulin-like growth factor-binding protein-1 and insulin in growth hormone-deficient patients and insulin-dependent diabetic patients compared to that in healthy subjects.
J Clin Endocrinol Metab1995https://conductscience.org/library/papers/7545695PubMed
1212767662Enhanced external counterpulsation improves endothelial function in patients with symptomatic coronary artery disease.J Am Coll Cardiol2003https://conductscience.org/library/papers/12767662PubMed
1317179929Mechanisms of Disease: endothelial dysfunction in insulin resistance and diabetes.Nat Clin Pract Endocrinol Metab2007https://conductscience.org/library/papers/17179929PubMed
1411869173Endothelin-1 inhibits endothelium-dependent vasodilatation in the human forearm: reversal by ETA receptor blockade in patients with atherosclerosis.Clin Sci (Lond)2002https://conductscience.org/library/papers/11869173PubMed
1516614356Role of nitric oxide in the regulation of digital pulse volume amplitude in humans.J Appl Physiol (1985)2006https://conductscience.org/library/papers/16614356PubMed
1621263120Relation of brachial and digital measures of vascular function in the community: the Framingham heart study.Hypertension2011https://conductscience.org/library/papers/21263120PubMed
1714693683Nitric oxide mediates protective effect of endothelin receptor antagonism during myocardial ischemia and reperfusion.Am J Physiol Heart Circ Physiol2004https://conductscience.org/library/papers/14693683PubMed
1820181680Assessment of endothelial function by non-invasive peripheral arterial tonometry predicts late cardiovascular adverse events.Eur Heart J2010https://conductscience.org/library/papers/20181680PubMed
1918458169Cross-sectional relations of digital vascular function to cardiovascular risk factors in the Framingham Heart Study.Circulation2008https://conductscience.org/library/papers/18458169PubMed
2016633080Enhanced endothelium-dependent vasodilatation by dual endothelin receptor blockade in individuals with insulin resistance.J Cardiovasc Pharmacol2006https://conductscience.org/library/papers/16633080PubMed

See all 26 referencesDownload CSV of references

Cited by33

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 63 citations.

PMIDTitleJournalYearIn PapersSource
41139358Overexpression of miR-454-3p inhibits high glucose-induced ET-1 expression, leading to eNOS upregulation in endothelial cells: an integrated bioinformatics and experimental analysis.Hum Cell2025https://conductscience.org/library/papers/41139358PubMed
40978470G protein-coupled receptor-mediated renal fibrosis: a key focus on kidney disease drug development.Front Pharmacol2025https://conductscience.org/library/papers/40978470PubMed
40722116Type II diabetes in systemic sclerosis patients: insights from an observational, multicenter study of GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale).Arthritis Res Ther2025https://conductscience.org/library/papers/40722116PubMed
40469998Endothelial dysfunction in single ventricle physiology and the Fontan circulation - What lies ahead.Int J Cardiol Congenit Heart Dis2025https://conductscience.org/library/papers/40469998PubMed
40203840Dual ETA-ETB receptor antagonism improves metabolic syndrome-induced heart failure with preserved ejection fraction.Fundam Clin Pharmacol2025https://conductscience.org/library/papers/40203840PubMed
40015728The role of endothelin receptor antagonists in kidney disease.Ren Fail2025https://conductscience.org/library/papers/40015728PubMed
37455912Epigenetic modification in diabetic kidney disease.Front Endocrinol (Lausanne)2023https://conductscience.org/library/papers/37455912PubMed
35977903Advances in the management of diabetic kidney disease: beyond sodium-glucose co-transporter 2 inhibitors.Kidney Res Clin Pract2022https://conductscience.org/library/papers/35977903PubMed
35861844Association of the Coexistence of Somnipathy and Diabetes With the Risks of Cardiovascular Disease Events, Stroke, and All-Cause Mortality: A Systematic Review and Meta-analysis.J Am Heart Assoc2022https://conductscience.org/library/papers/35861844PubMed
35317812Endothelial dysfunction and altered endothelial biomarkers in patients with post-COVID-19 syndrome and chronic fatigue syndrome (ME/CFS).J Transl Med2022https://conductscience.org/library/papers/35317812PubMed
35194565Erythrocytes Induce Vascular Dysfunction in COVID-19.JACC Basic Transl Sci2022https://conductscience.org/library/papers/35194565PubMed
34909290Endothelin Receptor Antagonists as a Potential Treatment of Diabetic Nephropathy: A Systematic Review.Cureus2021https://conductscience.org/library/papers/34909290PubMed
33269066Endothelin receptor antagonists for the treatment of diabetic nephropathy: A meta-analysis and systematic review.World J Diabetes2020https://conductscience.org/library/papers/33269066PubMed
32627269Endothelin-1 in the pathophysiology of obesity and insulin resistance.Obes Rev2020https://conductscience.org/library/papers/32627269PubMed
31460491Digital ulcers in systemic sclerosis and insulin-dependent diabetes mellitus type 2.Rheumatol Adv Pract2019https://conductscience.org/library/papers/31460491PubMed
31177906Endothelin Receptor Antagonism Improves Lipid Profiles and Lowers PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) in Patients With Chronic Kidney Disease.Hypertension2019https://conductscience.org/library/papers/31177906PubMed
29707151High levels of circulating endothelial progenitor cells in patients with diabetic retinopathy are positively associated with ARHGAP22 expression.Oncotarget2018https://conductscience.org/library/papers/29707151PubMed
29468936COPD as an endothelial disorder: endothelial injury linking lesions in the lungs and other organs? (2017 Grover Conference Series).Pulm Circ2018https://conductscience.org/library/papers/29468936PubMed
28327146Association between obstructive sleep apnea severity and endothelial dysfunction in patients with type 2 diabetes.Cardiovasc Diabetol2017https://conductscience.org/library/papers/28327146PubMed
27492897Targeting the ROS-HIF-1-endothelin axis as a therapeutic approach for the treatment of obstructive sleep apnea-related cardiovascular complications.Pharmacol Ther2016https://conductscience.org/library/papers/27492897PubMed

See all 33 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
EDN11906PubTator's text mininghttps://conductscience.org/library/genes/1906

Source NCBI Gene

Download CSV of genes

Drugs1

The drugs whose trials, in the Pipelines release, list the paper.

DrugChEMBL IDThe trials list it asTrialsIn Drugs and targets
BOSENTANCHEMBL957Derived from the trial1https://conductscience.org/library/drugs/CHEMBL957

Source ChEMBL

Download CSV of drugs

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/22200728

GET https://conductscience.org/api/papers/v1/22200728/references?page=2